August 31, 2018
The article focuses on FDNA’s pioneering efforts to address rare disease disorders through advanced AI technology. FDNA’s Face2Gene platform leverages artificial intelligence and facial recognition to identify rare genetic conditions by analyzing patients’ facial features. This innovative decision support tool aims to shorten the diagnostic journey, providing healthcare professionals with a powerful resource to detect rare disease disorders more accurately and efficiently. The article emphasizes how FDNA’s technology is transforming the landscape of genetic diagnostics, offering new avenues for early intervention and personalized care for individuals with rare conditions.
